MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients
Clinical trial NCT00078013 · COMPLETED
Trial details
- NCT number
- NCT00078013
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.